Apotex Seeking FDA Reconsideration Of Normocarb Drug Designation
This article was originally published in The Gray Sheet
Apotex wants FDA to designate its Normocarb pre-filter hemofiltration solution as a device instead of a drug in the hope that it can be cleared through the 510(k) process
You may also be interested in...
R. Sheridan Consulting is urging Congress to review FDA's criteria for determining whether a combination product should be regulated as a drug or a device
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.